Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2007-10-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0702596104PMID 17911267PMCID PMC2042178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention

  2006cited by this paper
• Cutting Edge: Lentiviral Short Hairpin RNA Silencing of PTEN in Human Mast Cells Reveals Constitutive Signals That Promote Cytokine Secretion and Cell Survival1

  2006cited by this paper
• Side population purified from hepatocellular carcinoma cells harbors cancer stem cell–like properties

  2006cited by this paper
• Profiling cancer stem cells using protein array technology.

  2006cited by this paper
• Stem cells in the etiology and treatment of cancer.

  2006cited by this paper
• Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

  2006cited by this paper
• A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells*

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice.

  2005cited by this paper
• Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.

  2004cited by this paper
• Mechanisms controlling pathogenesis and survival of leukemic stem cells

  2004cited by this paper
• A distinct "side population" of cells with high drug efflux capacity in human tumor cells.

  2004cited by this paper
• Regulation of c-Met-dependent gene expression by PTEN

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Cancer stem cells: are we missing the target?

  2004cited by this paper
• Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

  2003cited by this paper
• Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

  2003cited by this paper
• Survival of acute myeloid leukemia cells requires PI3 kinase activation.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Business Statistics in Practice

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

  2001cited by this paper
• Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

  2001cited by this paper
• The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

  2001cited by this paper
• Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR.

  2000cited by this paper
• Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

  1998cited by this paper
• Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

  1996cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper

• SOCS3-siRNA-loaded exosomes derived from adipose mesenchymal stem cells promote spinal cord injury recovery through the synergy between PTEN/PI3K/AKT/mTOR and JAK2/STAT3

  2026cites this paper
• Out of Nucleus: Serine 727 Phosphorylation Orchestrates Non-Canonical STAT3 Functions—Relevance to Triple-Negative Breast Cancer

  2026cites this paper
• Leishmania amazonensis infection induces PD-L1 expression on dendritic cells and impairs Th1 responses in vitro and in vivo

  2025cites this paper
• Targets and promising adjuvants for improving breast tumor response to radiotherapy.

  2025cites this paper
• Targeting MDA‐MB‐231 Cancer Stem Cells With Temsirolimus in 3D Collagen/PGA/Na2SiO3‐Based Bone Model

  2025cites this paper
• Metabolic regulation of Th17 and Treg cell balance by the mTOR signaling

  2025cites this paper
• Isoliquiritigenin Induces Apoptosis via ROS-Mediated Inhibition of p38/mTOR/STAT3 Pathway in Human Melanoma Cells

  2025cites this paper
• RNA-binding protein GIGYF2 promotes colorectal cancer progression through activation of the METTL3/SERP1/STAT3 axis in an m6A-IGF2BP2-dependent manner.

  2025cites this paper
• Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes

  2025influential citation
• Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation

  2025cites this paper
• mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy.

  2025cites this paper
• Stemness signatures reflect prognostic disturbances in gastric cancer

  2025cites this paper
• Niclosamide Treatment Suppressed Metastatic, Apoptotic, and Proliferative Characteristics of MDA-MB-231 Cancer Stem Cells

  2025cites this paper
• The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials

  2025cites this paper
• Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer

  2025cites this paper
• PTEN-deficient, chromosomal instability colorectal cancer is hypersensitive to STAT3 inhibition

  2025cites this paper
• Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.

  2025cites this paper
• Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities

  2025cites this paper
• Metformin prevents diabetes development in type 1 diabetes models via suppression of mTOR and STAT3 signaling in immune cells

  2025cites this paper
• Neuronal HDAC3 knockdown promotes propriospinal detour pathway formation and locomotor recovery in a mouse model of spinal cord injury.

  2025cites this paper
• Modulation of Master Transcription Factor Expression of Nile Tilapia Leukocytes via Cholinergic Pathways

  2025cites this paper
• Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity

  2025cites this paper
• The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy

  2025cites this paper
• MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer

  2025cites this paper
• Emerging roles of pseudogene-derived lncRNAs in cancer stem cells: Non-coding clues and therapeutic targets in cancer medicine

  2025cites this paper
• The Suppression of Signal Transducer and Activator of Transcription-3 in A549 human Lung Carcinoma Cells Induced by Marine Sponge Callyspongia aerizusa

  2025cites this paper
• Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients

  2025cites this paper
• Polyploidy and mTOR signaling: a possible molecular link

  2024cites this paper
• Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells' Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines.

  2024cites this paper
• Intricate relationship between cancer stemness, metastasis, and drug resistance

  2024cites this paper
• Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells

  2024cites this paper
• Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance

  2024cites this paper
• Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence

  2024cites this paper
• Helicobacter pylori CagA protein induces gastric cancer stem cell‐like properties through the Akt/FOXO3a axis

  2024cites this paper
• Targeting Cervical Cancer Stem Cells by Phytochemicals.

  2024cites this paper
• Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy

  2024cites this paper
• Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance

  2024cites this paper
• Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

  2024cites this paper
• Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.

  2024cites this paper
• SELF-ASSEMBLED LIPID NANOPARTICLES FOR KILLING TRIPLE NEGATIVE BREAST CANCER CELLS.

  2024cites this paper
• Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance.

  2024cites this paper
• ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia

  2024cites this paper
• Effects of BYL-719 (alpelisib) on human breast cancer stem cells to overcome drug resistance in human breast cancer

  2024cites this paper
• Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review

  2024cites this paper
• Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells

  2024cites this paper
• Radiosensitizing Effects of Metformin on Ionizing Irradiation: An Overview of Animal and Clinical Studies.

  2024cites this paper
• TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway

  2024cites this paper
• Stemness in solid malignancies: coping with immune attack

  2024cites this paper
• The Role of Ubiquitination and the E3 Ligase Nedd4 in Regulating Corneal Epithelial Wound Healing

  2024cites this paper
• Targeting Breast Cancer Stem Cells through Retinoids: A New Hope for Treatment.

  2023cites this paper
• Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA

  2023cites this paper
• Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

  2023cites this paper
• Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches

  2023cites this paper
• Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids

  2023cites this paper
• A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis

  2023cites this paper
• Oxidative stress regulation and related metabolic pathways in epithelial–mesenchymal transition of breast cancer stem cells

  2023cites this paper
• Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies

  2023cites this paper
• Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex

  2023cites this paper
• Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression.

  2023cites this paper
• Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)

  2023cites this paper
• Cells Resident to Precision Templated 40-µm Pore Scaffolds Generate Small Extracellular Vesicles that Affect CD4+ T Cell Phenotypes Through Regulatory TLR4 Signaling.

  2023cites this paper
• Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

  2023cites this paper
• BMP signaling in cancer stemness and differentiation

  2023cites this paper
• Mycochemicals against Cancer Stem Cells

  2023cites this paper
• mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma

  2023cites this paper
• Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

  2023cites this paper
• STAT3 regulates the generation of astroglia in human brain organoids with high mTORC1 activity

  2023cites this paper
• The Outside-In Journey of Tissue Transglutaminase in Cancer

  2022cites this paper
• Cancer Stem Cells: The Greatest Menace in Conquering Cancer Management

  2022cites this paper
• The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy

  2022cites this paper
• Porcine placenta extract upregulates ceramide synthase 3 expression via the PPARδ/ILK/Akt/mTOR/STAT3 pathway

  2022cites this paper
• Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

  2022cites this paper
• ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage

  2022cites this paper
• KRAB-ZFPs and cancer stem cells identity

  2022cites this paper
• Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression

  2022cites this paper
• Targeted liposomal doxorubicin/ceramides combinations: the importance to assess the nature of drug interaction beyond bulk tumor cells.

  2022cites this paper
• Leishmania amazonensis infection induces PD-L1 expression on dendritic cells in an mTor-dependent manner and impairs Th1 responses in vitro and in vivo

  2022cites this paper
• Understanding autophagy role in cancer stem cell development

  2022cites this paper
• Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway.

  2022cites this paper
• Application of Microfluidic Systems for Breast Cancer Research

  2022cites this paper
• PI3K/Akt/mTOR signaling pathway in cancer stem cells.

  2022cites this paper
• Polyphyllin VII as a potential drug for targeting stemness in hepatocellular cancer via STAT3 signaling.

  2022cites this paper
• Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways

  2022cites this paper
• Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques

  2022cites this paper
• Deregulated transcription factors in cancer cell metabolisms and reprogramming.

  2022cites this paper
• PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTOR

  2022influential citation
• Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance

  2022cites this paper
• Signaling pathways in the regulation of cancer stem cells and associated targeted therapy

  2022cites this paper
• Porcine Placenta Extract Enhances Ceramide Synthase 3 Expression through the PPAR<i>δ</i>/ILK/Akt/mTOR/STAT3 Pathway

  2022cites this paper
• Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.

  2022cites this paper
• Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties

  2022cites this paper
• PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma

  2022cites this paper
• Functional and Molecular Characters of Cancer Stem Cells Through Development to Establishment.

  2022cites this paper
• The Origin and Evolution of Bladder Cancer Stem Cells

  2022cites this paper
• STAT3-mediated effects of methyltransferase inhibitor 5-aza-2'-deoxycytidine on preeclampsia.

  2021cites this paper
• CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop

  2021cites this paper
• Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.

  2021cites this paper
• Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication

  2021cites this paper
• Immunohistochemical Expression of Leptin in Mammary Carcinoma

  2021cites this paper
• Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs

  2021cites this paper